8W0R
| Human EBP complexed with compound 1 | Descriptor: | 1-methyl-1'-[(oxan-4-yl)methyl]-5-(trifluoromethyl)spiro[indole-2,4'-piperidin]-3(1H)-one, 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | Authors: | Sun, D, Masureel, M. | Deposit date: | 2024-02-14 | Release date: | 2024-06-19 | Method: | ELECTRON MICROSCOPY (2.8 Å) | Cite: | Discovery and Optimization of Selective Brain-Penetrant EBP Inhibitors that Enhance Oligodendrocyte Formation. J.Med.Chem., 67, 2024
|
|
8W0L
| |
8W0J
| |
8W0H
| |
8W0D
| |
8W0C
| |
8W0B
| |
8W04
| |
8W01
| |
8VZR
| Crystal structure of dehaloperoxidase A in complex with substrate 4-bromo-o-cresol | Descriptor: | 4-bromo-2-methylphenol, DI(HYDROXYETHYL)ETHER, Dehaloperoxidase A, ... | Authors: | Aktar, M.S, de Serrano, V.S, Ghiladi, R.A, Franzen, S. | Deposit date: | 2024-02-12 | Release date: | 2024-07-17 | Last modified: | 2024-07-24 | Method: | X-RAY DIFFRACTION (1.64 Å) | Cite: | Structural Comparison of Substrate Binding Sites in Dehaloperoxidase A and B. Biochemistry, 63, 2024
|
|
8VZ9
| Crystal structure of mouse MAIT M2A TCR-MR1-5-OP-RU complex | Descriptor: | 1-deoxy-1-({2,6-dioxo-5-[(E)-propylideneamino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol, Beta-2-microglobulin, GLYCEROL, ... | Authors: | Ciacchi, L, Rossjohn, J, Awad, W. | Deposit date: | 2024-02-11 | Release date: | 2024-04-10 | Last modified: | 2024-05-08 | Method: | X-RAY DIFFRACTION (3.4 Å) | Cite: | Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil. J.Biol.Chem., 300, 2024
|
|
8VZ8
| Crystal structure of mouse MAIT M2B TCR-MR1-5-OP-RU complex | Descriptor: | 1-deoxy-1-({2,6-dioxo-5-[(E)-propylideneamino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol, Beta-2-microglobulin, GLYCEROL, ... | Authors: | Ciacchi, L, Rossjohn, J, Awad, W. | Deposit date: | 2024-02-11 | Release date: | 2024-04-10 | Last modified: | 2024-05-08 | Method: | X-RAY DIFFRACTION (3.45 Å) | Cite: | Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil. J.Biol.Chem., 300, 2024
|
|
8VY4
| Engineering a Tumor-Selective Prodrug T Cell Engager Bispecific Antibody for Safer Immunotherapy | Descriptor: | Fab Heavy Chain, Fab Light Chain, PCA-ASP-GLY-ASN-GLU-GLU-MET | Authors: | Antonysamy, S, Demarest, S, Froning, K, Hickey, M.H, Kuhlman, B, McCue, A.C. | Deposit date: | 2024-02-06 | Release date: | 2024-07-24 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy. Mabs, 16, 2024
|
|
8VWW
| CCHFV GP38 bound to ADI-46152 and ADI-58048 Fabs | Descriptor: | ADI-46152 Fab Heavy Chain, ADI-46152 Fab Light Chain, ADI-58048 Fab Heavy Chain, ... | Authors: | Hjorth, C.K, McLellan, J.S. | Deposit date: | 2024-02-02 | Release date: | 2024-07-24 | Method: | ELECTRON MICROSCOPY (3.9 Å) | Cite: | Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38. Cell Rep, 43, 2024
|
|
8VW4
| Crystal structure of Cbl-b TKB bound to compound 26 | Descriptor: | (7-methoxy-2-{2-[(1S,3S,4S)-3-(3-methoxy-2-methyl-5-nitrophenyl)-1-methyl-5-oxo-1,5-dihydroimidazo[1,5-a]pyridin-2(3H)-yl]-2-oxoethoxy}quinolin-8-yl)acetic acid, DI(HYDROXYETHYL)ETHER, E3 ubiquitin-protein ligase CBL-B, ... | Authors: | Yu, C, Murray, J, Hsu, P.L. | Deposit date: | 2024-01-31 | Release date: | 2024-07-03 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Optimization of a Novel DEL Hit That Binds in the Cbl-b SH2 Domain and Blocks Substrate Binding. Acs Med.Chem.Lett., 15, 2024
|
|
8VW2
| |
8VW1
| |
8VW0
| |
8VVL
| CCHFV GP38 bound to c13G8 Fab | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, CHLORIDE ION, ... | Authors: | Hjorth, C.K, Mishra, A.K, McLellan, J.S. | Deposit date: | 2024-01-31 | Release date: | 2024-07-17 | Last modified: | 2024-07-24 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38. Cell Rep, 43, 2024
|
|
8VVK
| CCHFV GP38 bound to ADI-46143 Fab | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ADI-46143 Fab Heavy Chain, ADI-46143 Fab Light Chain, ... | Authors: | Hjorth, C.K, McLellan, J.S. | Deposit date: | 2024-01-31 | Release date: | 2024-07-17 | Last modified: | 2024-07-24 | Method: | X-RAY DIFFRACTION (2.61 Å) | Cite: | Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38. Cell Rep, 43, 2024
|
|
8VUG
| Crystal Structure of human Tryptophan 2,3-dioxygenase in complex with PPN1 inhibitor | Descriptor: | (5P)-5-(1H-indol-3-yl)-1-[(piperidin-4-yl)methyl]-1H-benzotriazole, PROTOPORPHYRIN IX CONTAINING FE, Tryptophan 2,3-dioxygenase, ... | Authors: | Geeraerts, Z, Yeh, S. | Deposit date: | 2024-01-29 | Release date: | 2024-08-21 | Last modified: | 2024-09-11 | Method: | X-RAY DIFFRACTION (2.05 Å) | Cite: | Structural Insights into Protein-Inhibitor Interactions in Human Tryptophan Dioxygenase. J.Med.Chem., 67, 2024
|
|
8VTT
| Meis1 homeobox domain bound to neomycin fragment | Descriptor: | Homeobox protein Meis1, RIBOSTAMYCIN, SULFATE ION | Authors: | Tomchick, D.R, Ahmed, M.S, Nguyen, N.U.N, Sadek, H.A. | Deposit date: | 2024-01-27 | Release date: | 2024-02-14 | Last modified: | 2024-09-11 | Method: | X-RAY DIFFRACTION (2.45 Å) | Cite: | Identification of FDA-approved drugs that induce heart regeneration in mammals. Nat Cardiovasc Res, 3, 2024
|
|
8VTS
| Meis1 homeobox domain bound to paromomycin fragment | Descriptor: | 1,2-ETHANEDIOL, Homeobox protein Meis1, ISOPROPYL ALCOHOL, ... | Authors: | Tomchick, D.R, Ahmed, M.S, Nguyen, N.U.N. | Deposit date: | 2024-01-27 | Release date: | 2024-02-14 | Last modified: | 2024-09-11 | Method: | X-RAY DIFFRACTION (1.91 Å) | Cite: | Identification of FDA-approved drugs that induce heart regeneration in mammals. Nat Cardiovasc Res, 3, 2024
|
|
8VTQ
| Crystal Structure of human Tryptophan 2,3-dioxygenase in complex with PPN3 inhibitor | Descriptor: | (6M)-6-(1H-indol-3-yl)-1-[(piperidin-4-yl)methyl]-1H-benzotriazole, PROTOPORPHYRIN IX CONTAINING FE, Tryptophan 2,3-dioxygenase, ... | Authors: | Geeraerts, Z, Yeh, S.-R. | Deposit date: | 2024-01-26 | Release date: | 2024-08-21 | Last modified: | 2024-09-11 | Method: | X-RAY DIFFRACTION (2.05 Å) | Cite: | Structural Insights into Protein-Inhibitor Interactions in Human Tryptophan Dioxygenase. J.Med.Chem., 67, 2024
|
|
8VTO
| |